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The hepatotoxic effect of continous administration of cyfluthrin was investigated in rats. Rats (Rattus 
norvegicus) were grouped into A (0 ppm) control, B (100 ppm) and C (200 ppm) with the indicated 
amount of cyfluthrin administered orally for 15 weeks.The hepatotoxicity level was assessed by 
monitoring the changes in the organ to body; weight ratio, micronutrient level (iron, zinc, copper and 
selenium), the nutritional status (total carbohydrate, total glucose, total protein, total amino acids, total 
lipid and total cholesterol), the lipid peroxidation level (reduced glutathione and thiobarbiturate) and the 
antioxidant enzyme activities (glutathione peroxidase, glutathione reductase, catalase, and glucose-6-
phosphate dehydrogenase). A dose-dependent decrease in the organ-to-body ratio was observed. The 
micronutrient level in the test groups increase significantly. The total carbohydrate, total glucose, total 
amino acids and total protein show a significant decrease in the test groups. There is no significant 
difference observed in the tissue cholesterol at both dosages under investigation. Lipid peroxidation 
was increased in the test groups as indicated by a significant increase in the thiobarbiturate level and a 
significant decrease in the reduced glutathione level. All the antioxidant enzymes studied increased 
significantly. Cyfluthrin is potentially hepatotoxic under continuous administration in rats. 
 





Cyfluthrin is a synthetic type-2 pyrethroid insecticide. The 
original compound was isolated from the flower of 
chrysanthemum (Bloomquist, 1993). It has been effective 
in the control of a wide range of insects including 
cutworms, cockroaches, ants, termites, grain-beetle, 
weevil, fleas, flies and mosquitoes (Thompson, 1992). 
Due to its versatility it has become a useful active 
ingredient in the manufacture of many insecticides such 
as Baygon, Baythroid and Responsar (Meister, 1995). 
The mechanism of action of cyfluthrin has been traced to 
its interaction with sodium-ion-gated channels, leading to 
membrane depolarization and loss of electrical excitability 
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quist, 1996). Cyfluthrin has been reported to exhibit 
selective toxicity to insects, with sparingly low toxicity in 
mammals due to rapid liver metabolism and urinary 
excretion of both the metabolized and intact compound. 
However, laboratory animal exposed to relatively high 
doses of cyfluthrin had shown the same toxic effect 
observed in insects; including convulsion, salivation, 
ataxia, weakness and apathy (Schimmel, 1983). Also, 
report of dermal toxicity has been reported for skin 
contact (Moran, 1989). Due to the central role played by 
the liver in the detoxification of cyfluthrin, there is a 
tendency for its accumulation and subsequent toxicity to 
the liver, disrupting the normal hepatic function. 
Watanabe et al. (1982) reported liver necrosis and 
increased chromatin in the nuclei of hepatic cells after the 
administration of cyfluthrin. The absolute weight of the 
kidney was reported to decrease after the administration  
 
 




Table 1. Dry organ weight to body weight ratio (g/g) of 
rats administered with cyfluthrin. 
 




0.071±0.002 0.037*±0.001 0.051*±0.008 
 
Values are mean±SD. 
*Significant decrease (p<0.05) when compared with control. 
 
 
of cyfluthrin (Suberg and Loser, 1983). In this study, the 
hepatotoxic effect of continous administration of sub-
lethal dosages of cyfluthrin was monitored on the organ-
body ratios, micronutrient levels, nutritional status, and 
the antioxidant enzyme activities in the liver of rats. 
 
 




45 rats (Rattus norvegicus) between 80-95 g were obtained from 
the Animal House of the Department of Biochemistry, Igbinedion 
University Okada. They were grouped into three of 15 rats each 
(control 20% lecithin in water, 100 ppm and 200 ppm of cyfluthrin 
dissolved in 20% lecithin in water). 1 ml of the solution was 
administered daily by gavages for 15 weeks. At the end the 
treatment the animals were sacrificed under light anesthesia and 





Glutathione peroxidase assay is based on the oxidation of 
glutathione (GSH) to oxidized glutathione (GSSG) catalyzed by 
glutathione peroxidase (GPX) coupled to the recycling of GSSG 
back to GSH utilizing NADPH (Beutler et al., 1977). The decrease 
in NADPH absorbance measures at 340 nm is indicative of 
glutathione peroxidase activity. The glutathione reductase activity is 
a measure of increase in the absorbance at 412 nm of 5,5’-dithiobis 
(2-nitrobenzoic acid) when it is reduced by the enzyme (Smith et al,. 
1998). The in vitro catalase activity was determined using the 
modification of Ashiru and Singha (1971) method. Superoxide 
dismutase activity was estimated by Misra and Fridovish method 
(1972). Glucose-6-phosphate dehydrogenase activity was 
determined using the modification of Gupta and Baquer method 
(1998). 
Estimation of reduced glutathione level was determined by the 
method described by Moron et al. (1979). Thiobarbiturate level was 
determined by the modification of Ohokawa et al. (1979) method.  
 
 
Determination of nutritional status 
 
Total lipid in the tissue was determined using the soxhlet extractor 
method according to AOAC (1980). Total tissue nitrogen content 
was determined by the Kjedahl’s method (AOAC, 1980). The total 
carbohydrate was determined using the phenol/sulphuric acid 
method (Dubois et al., 1956). The cholesterol level was estimated 
using cholesterol oxidase method (Allain et al., 1974). Free glucose 
was determined by glucose oxidase method (Randox Kit). Total 
amino acid level was determined by the ninhydrin method (Magne 





Absorption spectrophotometer (Perkin-Elmer Analyst 100) was 
used in the determination of the micronutrient concentration after a 
wet digestion of the sample (perchlorate/HNO3) (3:2, v:v) using a 





The values are recorded as mean ± standard deviation. The 
statistical significance of difference in the mean and standard 
deviation (p<0.05) was analyzed by the student T-test for 
comparism of each of the test groups and the control. 
 
 
RESULTS AND DISCUSSION 
 
Table 1 shows the organ to body weight ratio. There is a 
significant decrease (p< 0.05) in the body-weight ratio at 
both dosages in a dose-depend manner. This agrees with 
the result of Oikawa and Iyatomi (1983) who reported 
decrease in the absolute weights of the liver, heart, and 
lungs in male rats at high cyfluthrin dosage, and females 
at this dose had depressed liver, kidney, adrenal, and 
ovarian weights. Shaw et al. (1983) reported the highest 
concentration of cyfluthrin in the liver when 0.5 mg/kg of 
cyfluthrin was administered daily for five days to a dairy 
cow. The accumulation of cyfluthrin in the liver is likely 
the primary factor which leads to the reduction in the 
absolute weight or the organ to body ratio. A reduction in 
the weight can be traced to two related mechanisms: a 
reduction in the rate of cell division which affects the 
genetic composition or through the necrosis of the tissue. 
Since cyfluthrin has no direct interaction with the DNA 
(Suberg.and Loser, 1983b), the reduction in tissue weight 
is most likely caused by tissue necrosis, possibly 
occurring at a basal rate. Gross pathological examination 
of hens administered high dose of cyfluthrin revealed 
spotty, brittle livers and pale, slightly mottled kidneys 
(Thyssen et al., 1981). 
Necrosis caused by cyfluthrin is possibly due to free 
radical generation, causing peroxidation of lipids as 
confirmed by significant increase in the thiobarbiturate 
levels in the test groups, and the significant reduction in 
the reduced glutathione level decreased significantly in 
the test groups at both dosages (Table 5). Oikawa and 
Iyatomi (1983) reported that rats treated with cyfluthrin at 
300 or 1000 mg/kg feed had significantly increased blood 
urea nitrogen levels, the blood glucose levels were 
depressed in males at 300 or 1000 mg/kg feed, and in 
females at 1000 mg/kg feed. Males at 1000 mg/kg feed 
had significantly increased liver aspartate amino 
transaminase activity. These parameters reveal that the 
metabolism in the liver is affected by cyfluthrin adminis-
tration. Table 2 shows the nutritional status of the liver 
indicating significant reduction in the total carbohydrate, 
total glucose and total lipid with the total protein decree-
sing in a dose-dependent manner. There is also a signifi-
cant  increase  in the total amino acid. There is no signifi- 




Table 2. Nutritional Status of tissue (mg/g of tissue) of rats administered with cyfluthrin. 
 
Nutrient Control Cyfluthrin (100 ppm) Cyfluthrin (200 ppm) 
Total Carbohydrate 61.22 ± 1.42 45.20*±3.22 38.36*± 3.56 
Total glucose 68.32± 20.33* ± 1.68 24.84*±0.15 
Total Protein 95.56±6.82 41.11*±6.18 24.87* ± 2.43 
Total Amino acid 06.18 ± 2.11 21.12* ± 2.14 11.01*±1.21 
Total Lipid 68.56 ± 1.11 22.51*± 5.11 20.15* ± 6.10 
Total Cholesterol 15.73±2.72 14.17 ± 1.54 16.30 ± 4.23 
 
Values are mean±SD * significant decrease (p<0.05) when compared with control. 
 * Significant increase (p<0.05) when compared with control. 
 
 
Table 3. Tissue Micronutrient Level in (µg/g) tissue of rats administered with cyfluthrin. 
 
Micronutrient Control Cyfluthrin (100 ppm) Cyfluthrin (200 ppm) 
Iron 281.71±11.43 232.21*±17.21 215.38*±21.03 
Zinc 119.21 ± 12.11 141.19* ± 11.25 131.79* ± 20.34 
Copper 85.15±5.32 196.35*±20.15 152.72* ±11.98 
Selenium 98.17±13.52 116.28* ± 23.54 124.12* ±21.96 
 
Values: (Mean ± SD).  * Significant increase (p<0.05) when compared with control 
 
 
Table 4.  Activity of anti-oxidant enzymes (U/L) of rats administered with cyfluthrin. 
 
Anti-oxidant enzyme Control Cyfluthrin (100 ppm) Cyfluthrin (200 ppm) 
Glutathione Peroxidase 51.13±4.11 107.18*±10.22 142.63*±13.71 
Glutathione Reductase 54.39±10.22 96.66*±6.18 88.96*±10.38 
Catalase 109.23±19.38 288.13*±12.67 126.17*±13.15 
Glucose-6-phosphate dehydrogenase 81.13±9.87 83.85 ± 2.56 108.86*±10.15 
 
Values: (Mean± SD). * Significant increase (P<0.05) when compared with control 
 
 
Table 5. Lipid peroxidation Level (mg/g of dry tissue) of rats administered with cyfluthrin. 
 
Parameter Control Cyfluthrin (100 ppm) Cyfluthrin (200 ppm) 
Thiobarbiturate level 45.78±5.18 108.96*±10.85 163.53*±16.77 
Reduced glutathione 75.18±11.56 25.80*±6.18 17.58*±8.12 
 




ficant difference in the cholesterol level in the tests 
groups under investigation.  
The carbohydrate are broken down for ATP formation 
which is required for the synthesis of protein needed for 
cyfluthrin detoxification, while some of the free glucose 
and amino acids are needed for the conjugation reaction. 
Since the metabolism has shifted to catabolism, there 
must be a halt on anabolism, especially the liver-derived 
lipids accounting for the reduction in the tissues levels of 
these metabolites.       
The possible explanation for the reduction in the total 
protein is likely due to proteolysis of structural protein 
(likely playing an important role in the reduction of the 
organ-body weight ratio) using their amino acids for 
translation of detoxifying enzyme synthesis, conjugation 
of cyfluthrin metabolite or for energy metabolism with the 
amino group channeled into urea cycle. This accounts for 
the high blood level of urea and liver aspartate 
transaminase leading to the hypoglycemia reported by 
Oikawa and Iyatomi (1983). The micronutrients studied 
(Table 3) were those that play important roles in the 
detoxification of free radical; some are cofactors to 
antioxidant enzyme studied (Table 4). Their analysis is 
necessary to establish the role of free radicals generation  
 
 




in the toxicity of cyfluthrin and its metabolites. The activity 
of the antioxidant enzymes, glutathione peroxidase 
increased significantly in both test groups when 
compared with the control. This may be due to increase 
in the concentration of selenium in the test groups. 
Glutathione peroxidase requires selenium for its optimum 
activity. Catalase is a hemoprotein that requires central 
iron for its catalysis. It plays important role in the 
detoxification of hydrogen peroxide. Catalase activity 
increased significantly in the test groups as also the iron 
levels. This means hydrogen peroxide generation plays 
important role in the toxicity of cyfluthrin. Copper and zinc 
play important roles in the three dimensional structures 
and catalysis of superoxide dismutase. There is a 
significant increase in the concentration of copper and 
zinc in the test groups. This is likely the reason for the 
increase in the glutathione peroxidase level, assisting 
catalase in the detoxification of the hydrogen peroxide 
and other peroxides generated from superoxide radical 
and superoxide dismutase. This clearly shows that under 
continous administration of cyfluthrin, superoxide radical 
is likely generated requiring the presence of Cu/Zn 
superoxide dismutase for detoxification. The oxidized 
glutathione produced during the detoxification of 
hydrogen peroxide must be reduced; this requires FAD-
dependent glutathione reductase, whose activity 
increased significantly in both test groups, confirming the 
role of free radical in the toxicity of cyfluthrin. The 
reducing equivalent needed for the reduction of the 
oxidized glutathione is ultimately derived from NADPH, 
which is also generated from glucose-6-phosphate, 
catalyzed by glucose-6-phosphate dehydrogenase, 
whose activity is slightly higher than the control at 100 
ppm, but significantly increases at 200 ppm concentration 
of cyfluthrin. This indicates that the extent of free radical 
generation is possibly dose-dependent. Thus, 
accumulation of cyfluthrin and its intermediates can 
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